|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investments, available for sale | ||||||||||||||||||||
| Marketable equity securities | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Contract asset (Note 12) | ||||||||||||||||||||
| Income taxes receivable, current | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Operating lease right-of-use asset, long-term | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities, current portion | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Deferred revenue, current portion | ||||||||||||||||||||
| Lease liability, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Accrued expenses, net of current portion | ||||||||||||||||||||
| Deferred revenue, long-term | ||||||||||||||||||||
| Deferred lease incentive, net of current portion | ||||||||||||||||||||
| Lease liability, net of current portion | ||||||||||||||||||||
| Warrant liabilities, long-term (Note 13) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value per share; 5,000,000 shares authorized; 32,500 shares designated as Series X1; 20,746 and 13,997 shares of Series X1 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | ||||||||||||||||||||
| Common stock, $0.001 par value per share; 200,000,000 and 100,000,000 shares authorized; 48,135,250 and 34,939,628 shares issued and 47,934,649 and 34,739,027 shares outstanding as of September 30, 2022 and December 31, 2021, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
